Lorenza Mittempergher
6PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.Denise M Wolf, Christina Yau, Michael Campbell
|Apr 18, 2024
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade.M C Liefaard, A van der Voort, M van Seijen
|Jan 18, 2024
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.Ian E Krop, Lorenza Mittempergher, Joseph N Paulson
|Sep 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.Tessa G Steenbruggen, Denise M Wolf, Bram Thijssen
|Aug 19, 2022
BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance.Midas M Kuilman, Architha Ellappalayam, Andrei Barcaru
|Jul 09, 2020
Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.Lorenza Mittempergher, Anna M Piskorz, Astrid J Bosma
Pageof 1
Frequent Collaborators
2 joint publications
Roberto Salgado
2 joint publications
Hugo M Horlings
2 joint publications
Annuska M Glas
1 joint publications
M C Liefaard
1 joint publications
B Thijssen
1 joint publications
L de Munck
1 joint publications
E H Lips
1 joint publications
Francesco Marass
1 joint publications
Tessa G Steenbruggen
1 joint publications
Joyce Sanders
